FibroGen, Inc.
bd_9feab6d21d5c516c · schema v1 · pii pii-v1
Full breach record for FibroGen, Inc. →Threat-actor claim — not a regulatory filing
This row is a claim by the ransomware group RansomHub on its public extortion blog. It has not been validated by the victim or any regulator. Treat attribution and counts as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Source: Ransomware.live
Post text · scraped from the leak site
FibroGen, Inc. is a biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies to treat serious unmet medical needs. The company focuses on areas such as fibrosis and oncology, with its lead product candidates targeting conditions like chronic kidney disease and anemia. FibroGen harnesses innovative technologies to develop first-in-class therapeutics.
Source provenance
- Source URL
- https://www.ransomware.live/
DisclosureLens links to the originating regulator URL — full filing bodies are not redistributed from public surfaces (§4.5).
- Filed at
- Nov 19, 2024
- Raw hash
- c6d14bebbd7af834aed4de4034990c08cbd9a4c76da095f6122c6a5aa2980001
Reporting entity
- Name
- ransomhub
Victim entity
- Name
- FibroGen, Inc.norm: fibrogen
- Domain
- fibrogen.com
- Industry
- Healthcare
What this source establishes
- Source ceiling
- A leak-site claim can't tell us: discovery date · materiality · notification · affected count · confirmed data types · compliance clock. These stay blank until a regulatory filing or victim disclosure lands.
- Attack vector
- Ransomware· ransomhub
- Threat actor
- RansomhubExternalFinancial
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.